A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
Clinical trial NCT01559272 · COMPLETED
Trial details
- NCT number
- NCT01559272
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-21
- Primary completion
- 2014-04-09
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.